Laurence Rodriguez
Chief Executive Officer at GENSIGHT BIOLOGICS S.A.
Laurence Rodriguez active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Director/Board Member | 15/01/2024 | - |
| Chief Executive Officer | 20/12/2023 | - | |
| Chief Operating Officer | 18/05/2021 | 20/12/2023 |
Career history of Laurence Rodriguez
Former positions of Laurence Rodriguez
| Companies | Position | Start | End |
|---|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Laurence Rodriguez
| Sciences Po | Graduate Degree |
Statistics
International
| France | 3 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private companies | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Laurence Rodriguez
- Experience
